Cited by

• Chronic Ca²⁺/Calmodulin-Dependent Protein Kinase II Inhibition Rescues Advanced Heart Failure.

  Liu Y, Shao Q, Cheng HJ, Li T, Zhang X, Callahan MF, Herrington D, Kitzman D, Zhao D, Cheng CP. Liu Y, et al. J Pharmacol Exp Ther. 2021 Jun;377(3):316-325. doi: 10.1124/jpet.120.000361. Epub 2021 Mar 15. J Pharmacol Exp Ther. 2021. PMID: 33722881 Free PMC article.
• Cell-cell communication: new insights and clinical implications.

  Su J, Song Y, Zhu Z, Huang X, Fan J, Qiao J, Mao F. Su J, et al. Signal Transduct Target Ther. 2024 Aug 7;9(1):196. doi: 10.1038/s41392-024-01888-z. Signal Transduct Target Ther. 2024. PMID: 39107318 Free PMC article. Review.
• Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice.

  Rouet-Benzineb P, Merval R, Polidano E. Rouet-Benzineb P, et al. Physiol Rep. 2018 Nov;6(21):e13912. doi: 10.14814/phy2.13912. Physiol Rep. 2018. PMID: 30430766 Free PMC article.
• Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.

  Meng Z, Li T, Ma X, Wang X, Van Ness C, Gan Y, Zhou H, Tang J, Lou G, Wang Y, Wu J, Yen Y, Xu R, Huang W. Meng Z, et al. Mol Cancer Ther. 2013 Oct;12(10):2067-77. doi: 10.1158/1535-7163.MCT-13-0314. Epub 2013 Aug 19. Mol Cancer Ther. 2013. PMID: 23960096 Free PMC article.
• Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents.

  Horváth B, Hézső T, Kiss D, Kistamás K, Magyar J, Nánási PP, Bányász T. Horváth B, et al. Front Pharmacol. 2020 Apr 20;11:413. doi: 10.3389/fphar.2020.00413. eCollection 2020. Front Pharmacol. 2020. PMID: 32372952 Free PMC article. Review.